Matthew Biegler Score: 28
Analyst at
Oppenheimer
Avg Return (Buy)
How much profit would you make?
Calculates the average return of all BUY recommendations after exactly 1 year (or today if newer).
Note: Sell ratings are ignored here to focus on investment potential.
Calculates the average return of all BUY recommendations after exactly 1 year (or today if newer).
Note: Sell ratings are ignored here to focus on investment potential.
-4.6%
1 Year Cap
Win Rate
How often is the direction correct?
Percentage of trades that are currently profitable.
• Buy: Stock price went UP 📈
• Sell: Stock price went DOWN 📉
Percentage of trades that are currently profitable.
• Buy: Stock price went UP 📈
• Sell: Stock price went DOWN 📉
45%
9 W / 11 L
Target Met
How often was the target reached?
Hits vs. Total.
Hits vs. Total.
50%
8 W / 8 L
Precision Hit
How often precise (±3%)?
Hits vs. Total.
Hits vs. Total.
13%
2 W / 14 L
Bullseye Hit
How often perfect (±1%)?
Hits vs. Total.
Hits vs. Total.
6%
1 W / 15 L
High Conviction
The "Brave" Trades (>20% Upside)
Win Rate only for recommendations where the analyst predicted a massive move (>20%).
Shows if they are right when they bet big.
Win Rate only for recommendations where the analyst predicted a massive move (>20%).
Shows if they are right when they bet big.
44%
8 W / 10 L
Long Wins
Success rate for BUY ratings
How often is the analyst right when saying "Buy"?
(Price went UP).
How often is the analyst right when saying "Buy"?
(Price went UP).
45%
9 W / 11 L
Short Wins
Success rate for SELL ratings
How often is the analyst right when saying "Sell"?
(Price went DOWN).
How often is the analyst right when saying "Sell"?
(Price went DOWN).
0%
0 W / 0 L
Coverage & Price Targets
| Date | Stock | Signal | Target | Start Price | Best Price (1Y) | Accuracy | Current Price |
|---|---|---|---|---|---|---|---|
| Mar 16, 2026 |
CytomX Therapeutics Inc
CTMX
|
BUY |
$12.00
Est. +49%
|
$8.03 | $8.20 |
Pending
|
$3.71
-53.8%
|
| Feb 24, 2026 |
ORIC Pharmaceuticals Inc
ORIC
|
BUY |
$15.00
Est. +28%
|
$11.71 | $14.52 |
Pending
|
$12.86
+9.8%
|
| Oct 10, 2025 |
Nurix Therapeutics Inc
NRIX
|
BUY |
$28.00
Est. +158%
|
$10.86 | $27.50 |
Precision Hit (±3%)
|
$26.14
+140.7%
|
| Sep 10, 2025 |
Tyra Biosciences Inc
TYRA
|
BUY |
$36.00
Est. +196%
|
$12.18 | $40.65 |
Target Met
|
$28.65
+135.2%
|
| Sep 08, 2025 |
Ideaya Biosciences Inc
IDYA
|
BUY |
$36.00
Est. +54%
|
$23.39 | $42.68 |
Target Met
|
$39.86
+70.4%
|
| Jul 31, 2025 |
CytomX Therapeutics Inc
CTMX
|
BUY |
$7.00
Est. +202%
|
$2.32 | $8.20 |
Target Met
|
$3.71
+59.9%
|
| Jul 10, 2025 |
Nurix Therapeutics Inc
NRIX
|
BUY |
$30.00
Est. +137%
|
$12.67 | $25.15 |
Miss
|
$26.14
+106.3%
|
| May 06, 2025 |
ORIC Pharmaceuticals Inc
ORIC
|
BUY |
$12.00
Est. +138%
|
$5.04 | $14.93 |
Target Met
|
$12.86
+155.2%
|
| Oct 31, 2024 |
Arvinas Inc
ARVN
|
BUY |
$40.00
Est. +45%
|
$27.66 | $28.83 |
Miss
|
$9.39
-66.1%
|
| Oct 15, 2024 |
Nurix Therapeutics Inc
NRIX
|
BUY |
$35.00
Est. +41%
|
$24.87 | $29.56 |
Miss
|
$26.14
+5.1%
|
| Aug 14, 2024 |
Nurix Therapeutics Inc
NRIX
|
BUY |
$27.00
Est. +23%
|
$21.92 | $29.56 |
Target Met
|
$26.14
+19.3%
|
| Aug 13, 2024 |
Acrivon Therapeutics Inc
ACRV
|
BUY |
$18.00
Est. +148%
|
$7.26 | $10.16 |
Miss
|
$2.13
-70.7%
|
| Aug 07, 2024 |
Ideaya Biosciences Inc
IDYA
|
BUY |
$53.00
Est. +48%
|
$35.86 | $40.74 |
Miss
|
$39.86
+11.2%
|
| Aug 01, 2024 |
Blueprint Medicines Corp
BPMC
|
BUY |
$130.00
Est. +27%
|
$102.05 | $129.65 |
Bullseye Hit (±1%)
|
$129.46
+26.9%
|
| Jul 08, 2024 |
Blueprint Medicines Corp
BPMC
|
BUY |
$125.00
Est. +7%
|
$116.55 | $128.78 |
Target Met
|
$129.46
+11.1%
|
| May 16, 2024 |
Arvinas Inc
ARVN
|
BUY |
$70.00
Est. +118%
|
$32.11 | $34.09 |
Miss
|
$9.39
-70.8%
|
| May 14, 2024 |
Acrivon Therapeutics Inc
ACRV
|
BUY |
$21.00
Est. +151%
|
$8.36 | $10.16 |
Miss
|
$2.13
-74.5%
|
| Mar 12, 2024 |
ORIC Pharmaceuticals Inc
ORIC
|
BUY |
$17.00
Est. +19%
|
$14.32 | $14.66 |
Miss
|
$12.86
-10.2%
|
| Sep 06, 2022 |
Blueprint Medicines Corp
BPMC
|
BUY |
$90.00
Est. +27%
|
$70.66 | - | - |
$129.46
+83.2%
|
| Dec 13, 2021 |
Fate Therapeutics Inc
FATE
|
BUY |
$135.00
Est. +176%
|
$48.98 | - | - |
$2.48
-94.9%
|
CytomX Therapeutics Inc
CTMX
Mar 16, 2026
Signal & Target
BUY
$12.00
Start Price
$8.03
Best Price (1Y)
$8.20
Current Price
$3.71
Return
-53.8%
ORIC Pharmaceuticals Inc
ORIC
Feb 24, 2026
Signal & Target
BUY
$15.00
Start Price
$11.71
Best Price (1Y)
$14.52
Current Price
$12.86
Return
+9.8%
Nurix Therapeutics Inc
NRIX
Oct 10, 2025
Signal & Target
BUY
$28.00
Start Price
$10.86
Best Price (1Y)
$27.50
Current Price
$26.14
Return
+140.7%
Tyra Biosciences Inc
TYRA
Sep 10, 2025
Signal & Target
BUY
$36.00
Start Price
$12.18
Best Price (1Y)
$40.65
Current Price
$28.65
Return
+135.2%
Ideaya Biosciences Inc
IDYA
Sep 08, 2025
Signal & Target
BUY
$36.00
Start Price
$23.39
Best Price (1Y)
$42.68
Current Price
$39.86
Return
+70.4%
CytomX Therapeutics Inc
CTMX
Jul 31, 2025
Signal & Target
BUY
$7.00
Start Price
$2.32
Best Price (1Y)
$8.20
Current Price
$3.71
Return
+59.9%
Nurix Therapeutics Inc
NRIX
Jul 10, 2025
Signal & Target
BUY
$30.00
Start Price
$12.67
Best Price (1Y)
$25.15
Current Price
$26.14
Return
+106.3%
ORIC Pharmaceuticals Inc
ORIC
May 06, 2025
Signal & Target
BUY
$12.00
Start Price
$5.04
Best Price (1Y)
$14.93
Current Price
$12.86
Return
+155.2%
Arvinas Inc
ARVN
Oct 31, 2024
Signal & Target
BUY
$40.00
Start Price
$27.66
Best Price (1Y)
$28.83
Current Price
$9.39
Return
-66.1%
Nurix Therapeutics Inc
NRIX
Oct 15, 2024
Signal & Target
BUY
$35.00
Start Price
$24.87
Best Price (1Y)
$29.56
Current Price
$26.14
Return
+5.1%
Nurix Therapeutics Inc
NRIX
Aug 14, 2024
Signal & Target
BUY
$27.00
Start Price
$21.92
Best Price (1Y)
$29.56
Current Price
$26.14
Return
+19.3%
Acrivon Therapeutics Inc
ACRV
Aug 13, 2024
Signal & Target
BUY
$18.00
Start Price
$7.26
Best Price (1Y)
$10.16
Current Price
$2.13
Return
-70.7%
Ideaya Biosciences Inc
IDYA
Aug 07, 2024
Signal & Target
BUY
$53.00
Start Price
$35.86
Best Price (1Y)
$40.74
Current Price
$39.86
Return
+11.2%
Blueprint Medicines Corp
BPMC
Aug 01, 2024
Signal & Target
BUY
$130.00
Start Price
$102.05
Best Price (1Y)
$129.65
Current Price
$129.46
Return
+26.9%
Blueprint Medicines Corp
BPMC
Jul 08, 2024
Signal & Target
BUY
$125.00
Start Price
$116.55
Best Price (1Y)
$128.78
Current Price
$129.46
Return
+11.1%
Arvinas Inc
ARVN
May 16, 2024
Signal & Target
BUY
$70.00
Start Price
$32.11
Best Price (1Y)
$34.09
Current Price
$9.39
Return
-70.8%
Acrivon Therapeutics Inc
ACRV
May 14, 2024
Signal & Target
BUY
$21.00
Start Price
$8.36
Best Price (1Y)
$10.16
Current Price
$2.13
Return
-74.5%
ORIC Pharmaceuticals Inc
ORIC
Mar 12, 2024
Signal & Target
BUY
$17.00
Start Price
$14.32
Best Price (1Y)
$14.66
Current Price
$12.86
Return
-10.2%
Blueprint Medicines Corp
BPMC
Sep 06, 2022
Signal & Target
BUY
$90.00
Start Price
$70.66
Best Price (1Y)
-
Current Price
$129.46
Return
+83.2%
Fate Therapeutics Inc
FATE
Dec 13, 2021
Signal & Target
BUY
$135.00
Start Price
$48.98
Best Price (1Y)
-
Current Price
$2.48
Return
-94.9%